COMPANY NAME |
REVENUES 12 Months Ending Q4 2024 |
MARKET SHARE 12 Months Q4 2024 |
MARKET SHARE MRQ Q4 2024 |
MARKET SHARE A Quarter Before Q3 2024 |
Theravance Biopharma inc |
64.38 |
0.01% |
0.01 % |
0.01 % |
Paratek Pharmaceuticals Inc |
166.64 |
0.03% |
0.02% |
0.05% |
Amgen Inc |
33,424.00 |
5.26% |
5.52% |
5.17% |
Gilead Sciences Inc |
28,754.00 |
4.52% |
4.60% |
4.59% |
Vertex Pharmaceuticals Inc |
11,020.10 |
1.73% |
1.77% |
1.69% |
Biomarin Pharmaceutical Inc |
2,853.92 |
0.45% |
0.45% |
0.45% |
Regeneron Pharmaceuticals Inc |
14,202.00 |
2.23% |
2.30% |
2.26% |
Moderna Inc |
3,236.00 |
0.51% |
0.59% |
1.13% |
Illumina Inc |
4,372.00 |
0.69% |
0.67% |
0.66% |
Liquidia Corporation |
15.61 |
0.00% |
0.00% |
0.00% |
Nektar Therapeutics |
93.14 |
0.01% |
0.01% |
0.01% |
Pepgen Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ngm Biopharmaceuticals Inc |
4.42 |
0.00% |
0.00% |
0.00% |
Qualigen Therapeutics Inc |
4.79 |
0.00% |
0.00% |
0.00% |
Larimar Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Inozyme Pharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Kamada Ltd |
142.52 |
0.02% |
0.02% |
0.00% |
Amicus Therapeutics inc |
527.35 |
0.08% |
0.09% |
0.09% |
Alnylam Pharmaceuticals Inc |
2,248.24 |
0.35% |
0.36% |
0.30% |
Catalyst Pharmaceuticals Inc |
491.73 |
0.08% |
0.09% |
0.08% |
Sage Therapeutics Inc |
41.24 |
0.01% |
0.01% |
0.01% |
Comera Life Sciences Holdings Inc |
1.10 |
0.00% |
0.00% |
0.00% |
Insmed Inc |
278.56 |
0.04% |
0.04% |
0.04% |
Aptevo Therapeutics Inc |
12.99 |
0.00% |
0.00% |
0.00% |
Ultragenyx Pharmaceutical Inc |
560.23 |
0.09% |
0.10% |
0.08% |
Pharming Group N v |
245.10 |
0.04% |
0.00% |
0.12% |
Agios Pharmaceuticals Inc |
36.50 |
0.01% |
0.01% |
0.01% |
Apellis Pharmaceuticals Inc |
781.37 |
0.12% |
0.13% |
0.12% |
Axsome Therapeutics Inc |
399.43 |
0.06% |
0.10% |
0.05% |
Aptinyx Inc |
1.75 |
0.00% |
0.00% |
0.00% |
Aeon Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cohbar Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Paxmedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acer Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nls Pharmaceutics Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Nrx Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Impel Pharmaceuticals Inc |
8.22 |
0.00% |
0.00% |
0.00% |
Ovid Therapeutics Inc |
0.57 |
0.00% |
0.00% |
0.00% |
Adhera Therapeutics Inc |
2,732.01 |
0.43% |
0.00% |
0.00% |
Alkermes Plc |
1,557.63 |
0.24% |
0.26% |
0.23% |
Amylyx Pharmaceuticals Inc |
196.49 |
0.03% |
0.00% |
0.00% |
Gossamer Bio Inc |
0.00 |
0.00% |
0.01% |
0.06% |
Acadia Pharmaceuticals Inc |
929.24 |
0.15% |
0.15% |
0.15% |
Vanda Pharmaceuticals Inc |
198.77 |
0.03% |
0.03% |
0.03% |
Intra cellular Therapies Inc |
680.85 |
0.11% |
0.12% |
0.11% |
Synaptogenix Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Bioxcel Therapeutics Inc |
2.28 |
0.00% |
0.00% |
0.00% |
Eli Lilly And Company |
45,042.70 |
7.08% |
8.23% |
6.96% |
Protagenic Therapeutics Inc new |
0.00 |
0.00% |
0.00% |
0.00% |
Conduit Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Karuna Therapeutics Inc |
11.29 |
0.00% |
0.00% |
0.00% |
Climb Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Neurobo Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gain Therapeutics Inc |
0.21 |
0.00% |
0.00% |
0.00% |
Vistagen Therapeutics Inc |
0.88 |
0.00% |
0.00% |
0.00% |
Zevra Therapeutics Inc |
24.79 |
0.00% |
0.00% |
0.00% |
Cassava Sciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Praxis Precision Medicines Inc |
8.55 |
0.00% |
0.00% |
0.00% |
Xenon Pharmaceuticals Inc |
13.17 |
0.00% |
0.00% |
0.00% |
Cerevel Therapeutics Holdings Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mannkind Corporation |
285.50 |
0.04% |
0.05% |
0.04% |
Arcus Biosciences Inc |
258.00 |
0.04% |
0.02% |
0.03% |
Arvinas Inc |
263.40 |
0.04% |
0.04% |
0.06% |
Fibrogen Inc |
180.01 |
0.03% |
0.03% |
0.03% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Puma Biotechnology Inc |
230.47 |
0.04% |
0.04% |
0.05% |
Innoviva Inc |
417.87 |
0.07% |
0.05% |
0.06% |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Myovant Sciences Ltd |
379.11 |
0.06% |
0.06% |
0.06% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Nabriva Therapeutics Plc |
29.56 |
0.00% |
0.00% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics inc |
0.00 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
0.65 |
0.00% |
0.00% |
0.00% |
Legend Biotech Corporation |
285.14 |
0.04% |
0.04% |
0.00% |
Beigene Ltd |
3,314.38 |
0.52% |
0.61% |
0.57% |
Organon and Co |
6,403.00 |
1.01% |
0.97% |
0.96% |
Teva Pharmaceutical Industries Limited |
16,545.00 |
2.60% |
2.57% |
2.63% |
Viatris Inc |
14,739.30 |
2.32% |
2.15% |
2.28% |
Astrazeneca Plc |
45,811.00 |
7.20% |
7.20% |
0.00% |
Sanofi |
49,599.72 |
7.80% |
7.80% |
0.00% |
Novartis Ag |
46,660.00 |
7.34% |
7.34% |
0.00% |
Medicure Inc |
16.62 |
0.00% |
0.00% |
0.00% |
Gri Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Nanoviricides inc |
0.00 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Esperion Therapeutics inc |
332.31 |
0.05% |
0.04% |
0.03% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Journey Medical Corp |
57.77 |
0.01% |
0.01% |
0.01% |
Casi Pharmaceuticals inc |
30.17 |
0.00% |
0.01% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.59% |
4.59% |
0.00% |
Bicycle Therapeutics Plc |
35.28 |
0.01% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Anaptysbio Inc |
91.28 |
0.01% |
0.03% |
0.02% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Johnson and Johnson |
88,821.00 |
13.97% |
13.69% |
13.67% |
Merck and Co Inc |
64,168.00 |
10.09% |
9.50% |
10.13% |
Bristol myers Squibb Company |
48,300.00 |
7.60% |
7.50% |
7.23% |
Pfizer Inc |
63,627.00 |
10.01% |
10.80% |
10.77% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
635,840.44 |
100% |
164,477.02 |
100% |